Skip to content
Finance Investment, Oil Mining Resources

Aurumin Limited (ASX: AUN) – Sale of Mt Dimer Mining Tenements – Progress Update

Aurumin Limited (ASX: AUN) 2 mins read

Aurumin Limited (ASX: AUN), an ASX-listed mineral exploration Company focused on two project areas in Western Australia, is delighted to announce the successful execution of a Tenement Sale Agreement with Beacon Minerals Ltd for the divestment of its Mt Dimer mining leases and miscellaneous licenses, collectively known as the Mt Dimer Mining Tenements. These tenements, hosting the high-grade Lightning and Golden Slipper Deposits, are strategically located 120km north-east of Southern Cross.

Highlights of the Sale:

  • The transaction includes the sale of mining tenements M77/427, M77/428, M77/957, M77/958, M77/965, P77/4568, L77/0083, L77/0135, L77/0147, and several applications for additional licenses.
  • Aurumin will receive a cash consideration of $3.0M upon the completion of the sale.
  • Additionally, the company is set to receive a 2% net smelter return royalty on gold production from these tenements exceeding 12,000 ounces, as well as on all other minerals produced.

Progress on Conditions Precedent:

  • Completed conditions include Beacon's satisfactory due diligence, the execution of the formal sale agreement, and the royalty agreement.
  • Remaining conditions to be fulfilled include the execution of access agreements, assignment or novation of relevant third-party agreements, obtaining all necessary regulatory, statutory, and ASX approvals, and the release of all security interests over the Mt Dimer Mining Tenements, excluding existing royalties.
  • These conditions are expected to be satisfied by 15 December 2023, or a later date as agreed between the parties.

Use of Proceeds:

The proceeds from this sale are earmarked for reducing the outstanding balance of the Convertible Note held by CollinsStreet Asset Management Pty Ltd, as previously announced on 15 December 2021.

This sale marks a significant milestone for Aurumin Limited, aligning with our strategic focus and commitment to enhancing shareholder value. We look forward to a smooth completion of the remaining conditions and a fruitful partnership with Beacon Minerals Ltd.


About us:

Aurumin Limited is an ASX-listed mineral exploration Company focused on two project areas in Western Australia. 


Contact details:

Jane Morgan

[email protected]

Media

More from this category

  • Human Resources, Oil Mining Resources
  • 16/04/2026
  • 16:57
Bell Bay Joint Unions

Unions call on Tasmanian, Australian governments to back Liberty Bell Bay workers ahead of sale

Unions representing hundreds of workers at Liberty Bell Bay have called on the Tasmanian and Federal Governments to move urgently to guarantee workers’ wages, after the site’s administrator told 181 workers to take leave without pay next week or be sacked. 216 workers at the strategically vital manganese smelter received the chilling ultimatum at 10am today, with only 35 workers to be kept on. Administration is expected to run for months before any sale. But as it stands, the administrator only has funding to deliver all workers their wages until 24 April. This is despite the administrator telling workers it…

  • Business Company News, Oil Mining Resources
  • 16/04/2026
  • 15:33
Jane Morgan Management

Extraction rates in excess of 90%, the reality of urban mining of e-waste for rare earth elements is one step closer with Iondrive’s latest results

Key Facts: Working towards a solution for the recycling of e-waste and solar panels. A potential pathway to domestic supply of rare earth elements.…

  • Contains:
  • Finance Investment, Medical Health Aged Care
  • 16/04/2026
  • 15:21
JMM

BlinkLab Secures A$17.5M to Advance FDA Trial and Commercial Launch of AI-Powered Autism Diagnostic, Expands ADHD Program

BlinkLab Limited (ASX: BB1) a digital healthcare company developing AI-powered diagnostic technologies, has secured A$17.5 million in an oversubscribed placement to institutional and sophisticated investors, positioning the Company to accelerate regulatory milestones and commercialisation of its lead autism diagnostic platform while expanding into the significantly larger ADHD market. The capital raise, priced at A$0.65 per share, marks a critical inflection point for BlinkLab as it advances toward FDA approval and market entry for BlinkLab Dx1, its smartphone-based diagnostic aid for autism. Funding to Accelerate Regulatory Pathway and Commercial Readiness Proceeds from the placement will be deployed across key value-driving initiatives,…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.